151 related articles for article (PubMed ID: 33421566)
41. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
Kim Y; Roh JL; Song D; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2020 Oct; 122(5):906-913. PubMed ID: 32588461
[TBL] [Abstract][Full Text] [Related]
42. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
43. Lymphovascular invasion is associated with survival for papillary thyroid cancer.
Pontius LN; Youngwirth LM; Thomas SM; Scheri RP; Roman SA; Sosa JA
Endocr Relat Cancer; 2016 Jul; 23(7):555-62. PubMed ID: 27317633
[TBL] [Abstract][Full Text] [Related]
44. Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
Semrad TJ; Keegan THM; Semrad A; Brunson A; Farwell DG
Thyroid; 2018 Sep; 28(9):1143-1152. PubMed ID: 29929451
[TBL] [Abstract][Full Text] [Related]
45. Airtight tracheocutaneostomy after window resection of the trachea for invasive papillary thyroid carcinoma: experience of 109 cases.
Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
World J Surg; 2014 Mar; 38(3):660-6. PubMed ID: 23982781
[TBL] [Abstract][Full Text] [Related]
46. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
47. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
48. Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis.
Wrenn SM; Wang TS; Toumi A; Kiernan CM; Solórzano CC; Stephen AE
Am J Surg; 2021 Feb; 221(2):448-454. PubMed ID: 32933747
[TBL] [Abstract][Full Text] [Related]
49. Trends and Outcomes of Surgical Management of Primary Papillary Carcinoma in the Pediatric Population.
Sharma RK; Huang B; Lee JA; Kuo JH
J Surg Res; 2021 Jul; 263():207-214. PubMed ID: 33690052
[TBL] [Abstract][Full Text] [Related]
50. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
[TBL] [Abstract][Full Text] [Related]
51. TIMING OF RADIOACTIVE IODINE THERAPY DOES NOT IMPACT OVERALL SURVIVAL IN HIGH-RISK PAPILLARY THYROID CARCINOMA.
Suman P; Wang CH; Abadin SS; Block R; Raghavan V; Moo-Young TA; Prinz RA; Winchester DJ
Endocr Pract; 2016 Jul; 22(7):822-31. PubMed ID: 27018620
[TBL] [Abstract][Full Text] [Related]
52. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
Clayman GL; Agarwal G; Edeiken BS; Waguespack SG; Roberts DB; Sherman SI
Thyroid; 2011 Dec; 21(12):1309-16. PubMed ID: 22136266
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
54. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
55. A UK based two-centre review of multifocality and its role in the treatment of papillary thyroid cancer.
Li LQ; Hey SY; Andreeva D; Tornari C; Sawant R; Harding NE; Adamson R; Hay A; Simo R; Nixon IJ
Eur J Surg Oncol; 2022 Jan; 48(1):14-20. PubMed ID: 34253424
[TBL] [Abstract][Full Text] [Related]
56. Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
McDow AD; Roman BR; Saucke MC; Jensen CB; Zaborek N; Jennings JL; Davies L; Brito JP; Pitt SC
Am J Surg; 2021 Jul; 222(1):111-118. PubMed ID: 33248684
[TBL] [Abstract][Full Text] [Related]
57. The optimal surgical approach for papillary thyroid carcinoma with pathological n1 metastases: An analysis from the SEER database.
Ji T; Chen J; Mou J; Ni X; Guo Y; Zhang J; Wang S; Wang W; Zhang X; Tai J
Laryngoscope; 2020 Jan; 130(1):269-273. PubMed ID: 30953386
[TBL] [Abstract][Full Text] [Related]
58. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Value of Tumor Multifocality in Pediatric Papillary Thyroid Carcinoma: A Real-Life Multicentric Study.
Xu Y; Shi L; Wu J; Li H; Wang Y; Liu B
Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1606-1614. PubMed ID: 37222185
[TBL] [Abstract][Full Text] [Related]
60. Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.
MacKinney EC; Kuchta KM; Winchester DJ; Khokar AM; Holoubek SA; Moo-Young TA; Prinz RA
Surgery; 2022 Jan; 171(1):197-202. PubMed ID: 34666913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
